Hepatits C

Ledipasvir-Sofosbuvir Treatment for Chronic Hepatitis C Virus Infection

Ledipasvir-Sofosbuvir Treatment for Chronic Hepatitis C Virus Infection

By

Ledipasvir-sofosbuvir treatment for chronic HCV infection may be efficacious, safe, and tolerable for HCV genotype 1 and 4.

Glecaprevir/Pibrentasvir Effective, Well-Tolerated in Older HCV Patients

Glecaprevir/Pibrentasvir Effective, Well-Tolerated in Older HCV Patients

By

Due to the limited amount of published literature analyzing treatment options for older chronic HCV infection patients, the study authors aimed to determine the efficacy and tolerability of glecaprevir/pibrentasvir in this population.

HIV & Cancer Risk: Expert Interview

HIV & Cancer Risk: Expert Interview

By

Although rates of AIDS-defining malignancies have declined in recent decades, cancer remains a leading cause of mortality in people living with HIV.

Survival Similar With Donor Hearts From Donors With Hepatitis C

Survival Similar With Donor Hearts From Donors With Hepatitis C

Transplant patients with hearts from donors with HCV infection and obese donors have similar survival rates as patients with other donor hearts.

Sustained Hepatitis C Treatment Associated With Lower Risk for Cardiovascular Events

Sustained Hepatitis C Treatment Associated With Lower Risk for Cardiovascular Events

By

Treatment for hepatitis C is associated with a reduction in cardiovascular events.

Sign Up for Free e-newsletters